Interactome networks: the state of the science by Warner, Guy J et al.
Genome Biology 2006, 7:301
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
Meeting report
Interactome networks: the state of the science
Guy J Warner*, Yeyejide A Adeleye* and Trey Ideker†
Addresses: *Safety and Environmental Assurance Centre, Unilever Colworth Laboratory, Sharnbrook, Bedfordshire MK44 1LQ, UK.
†Department of Bioengineering, University of California San Diego, 9500 Gilman Drive, Mail Code 0412, La Jolla, CA 92093, USA.
Correspondence: Guy J Warner. Email: Guy.Warner@Unilever.com
Published: 23 January 2006
Genome Biology 2006, 7:301 (doi:10.1186/gb-2006-7-1-301)
The electronic version of this article is the complete one and can be
found online at http://genomebiology.com/2006/7/1/301
© 2006 BioMed Central Ltd 
A report on the joint Cold Spring Harbor/Wellcome Trust
Meeting ‘Interactome Networks’, Hinxton, UK, 31 August-
4 September 2005.
High-throughput analyses are identifying the DNA, RNA,
proteins and metabolites within a biological system with
increasing accuracy and speed. As a result, we now have a
relatively detailed understanding of the components that
make up the dynamic and temporal characteristics of the
cell. In most cases, however, we know very little about how
the individual components work together to carry out spe-
cific biological functions. To get over this hurdle, it will be
necessary to map how individual biomolecules interact with
one another within a larger network of molecular interac-
tions (the so-called ‘interactome’) in the cell as a whole.
Mapping this network is the shared goal of an increasing
number of researchers from the UK, Europe, US, and Japan,
who gathered at the first annual Cold Spring Harbor/Wellcome
Trust meeting on interactome networks in Hinxton. This
meeting provided an opportunity to review the recent exper-
imental and computational advances that have been applied
to uncover biomolecular interactions. Here we report a few
of the key advances in the areas of new interaction-mapping
techniques, new experimental reagents and resources, and
new computational tools for understanding interaction net-
works that were presented at the meeting.
Assays for interactome network mapping
Although tens of thousands of protein interactions have
been uncovered so far, these are only a small part of the
complete set of pairwise interactions between all proteins.
Therefore, one of the main themes at the meeting dealt with
current approaches and resources available for mapping
interactions efficiently across a variety of organisms, includ-
ing  Saccharomyces cerevisiae, Caenorhabditis elegans,
Danio rerio, Drosophila melanogaster and humans. Chris
Sanderson (University of Liverpool, UK) described how the
focused application of the yeast two-hybrid system can
provide insights into disease pathways. Protein-protein net-
works were generated for specific biological processes
(including DNA degradation, multivesicular formation and
ubiquitin conjugation) using stringent yeast two-hybrid
screens, and the resulting protein-protein interaction net-
works were used to gain insights into the role of previously
uncharacterized proteins in hereditary spastic paraplegia,
which is most commonly caused by mutations in the gene
(SG4) for the protein spastin. Several proteins were identi-
fied as interacting partners with spastin, including one
called CHMP1B, which is associated with the endosomal
sorting complex required for transport (ESCRT) III. This
suggests that spastin has a role in intracellular membrane
trafficking, supporting the hypothesis that defects in intra-
cellular membrane traffic are a significant cause of motor
neuron pathology. 
An alternative interaction mapping strategy was described by
Anne-Claude Gavin of Cellzome (Heidelberg, Germany). Cell-
zome has a long track record of applying tandem affinity purifi-
cation (TAP) in conjunction with liquid-chromatography
tandem mass spectrometry (LC-MS/MS) to map protein
interactions, and Gavin reported that this integrated
approach has now been used to elucidate protein interac-
tions in the pathway mediated by tumor necrosis factor 
(TNF) and the transcription factor NFB. Cellular com-
plexes containing one or more of 32 TNF/NFB pathway
components were isolated using TAP and then screened in
vivo for both constitutive and signal-induced protein inter-
actions. A total of 680 interacting proteins were identified
using LC-MS/MS, of which 33 were dependent on stimula-
tion with TNF or NFB-inducing kinase. Upon filtering thenetwork for specificity and consistency, 131 high-confidence
interactors remained. Network analysis combined with
sequence information for the proteins was then used to
select 28 candidates for functional validation using system-
atic directed perturbation by RNA interference (RNAi), in
which ten proteins showed reproducible responses consis-
tent with a modulatory role in TNF/NFB signal transduc-
tion. This combined and rigorous elucidation of a
medium-scale map of human protein interactions shows
that specific components of human pathways can be eluci-
dated and subsequently validated with RNAi. 
Another approach to the determination of protein complexes
was covered by Oda Stoevesandt (University of Tübingen,
Germany), who used a combination of peptide microarrays
and fluorescence spectroscopy to investigate the early stages
of T-cell signaling. Microarrays of peptides corresponding
to motifs that interact with binding domains of signaling
proteins were used to detect activation-dependent changes
in protein-protein interaction patterns; proteins binding to
the array were detected by indirect immunofluorescence
techniques. Stoevesandt suggested that such a method can
detect protein interactions more rapidly than established
techniques.
Resources for interaction mapping projects
A prerequisite for determining a protein interaction network
ab initio is to clone the open reading frames (ORFs) that
encode each protein in the network. Gary Temple (National
Institutes of Health, Bethesda, USA) discussed the work
being done by the Mammalian Genome Collection (MGC)
[http://mgc.nci.nih.gov], which aims to provide a commu-
nity resource of publicly accessible full-length ORF clones of
human and mouse protein-coding genes. At the time of
writing, MGC has more than 20,000 and 16,000 full ORF
clones for human and mouse, respectively.
Susan Celniker (Lawrence Berkeley National Laboratory,
Berkeley, USA) presented the work being done by the Berkeley
Drosophila Genome Project to produce the Drosophila Gene
Collection (DGC) [http://www.fruitfly.org/DGC], a resource
of sequenced full-length D. melanogaster cDNAs. She also
stressed the importance of accurately annotating the genomic
sequences in such collections, which should include data that
allow the temporal and spatial patterns of the expression of
the genes to be understood. Studies that require the use of
such ORFeome resources can be adversely affected by inaccu-
racies in gene prediction and annotation. An attempt to
improve the quality and coverage of the C. elegans ORFeome
resource Worfdb [http://worfdb.dfci.harvard.edu] was
detailed by Philippe Lamesch of Marc Vidal’s group (Dana-
Farber Cancer Institute, Boston, USA). The first version of
the database was based on an early release of the genome
sequence (Wormbase WS9), and since then there has been a
continuous effort to further annotate and better predict
coding regions. Lamesch presented recent work to update
Worfdb with newly predicted ORFs; approximately 12,500
ORFs are now available that can be characterized using high-
throughput techniques, including yeast two-hybrid
approaches. This type of iterative ORFeome construction was
strongly supported at the meeting and argues that the complete
cloning of an organism’s coding regions must be an ongoing
process that takes into account improved gene predictions and
incorporates strong experimental validation through PCR.
Jean-François Rual (also from Vidal’s group) described how
their resource of approximately 8,000 MGC clones trans-
ferred into Gateway entry vectors from Invitrogen, has been
used to perform large-scale screens for human protein-
protein interactions. A stringent yeast two-hybrid system
was used to test all possible pairwise interactions between
the products of the ORF clones, from which around 2,800
high-confidence interactions were detected, with 80% of
them being were verified using co-affinity purification. 
Rual’s talk, along with several others, highlighted a major
shift in interaction research from model species to human:
two other human interaction networks were described at the
meeting by Ulrich Stelzl (Max Delbrück Center for Molecular
Medicine, Berlin, Germany) and Anne-Claude Gavin, respec-
tively, based on primary mass spectrometry or two-hybrid
assays. Interestingly, as is typical for high-throughput inter-
action screens, these new human interaction datasets have
little apparent overlap with each other or with the previous
literature. Although this situation could arise because of
false-positive interactions (and it is difficult to rule these
out), the principal cause is probably related to the low
overall coverage of interactions: that is, if a single study
sampled one fifth of the ‘true’ network, the expected overlap
between two such studies would also equal one fifth - a
seemingly low number. It was suggested that the community
could collectively work to maximize coverage by producing
‘networks of networks’, built up from separate interaction-
mapping initiatives, each of which would target a specific
functionally related subset of proteins and interactions.
Computational analyses and tools for studying
interactome networks 
Apart from the recent high-throughput interaction datasets,
interactions reported in the past scientific literature represent
another valuable resource. Given the overwhelming number
of relevant articles, the challenge is to effectively extract these
interaction data from the literature. Along these lines,
Edward Marcotte (University of Texas, Austin, USA)
described a bioinformatic approach to predict human protein
interactions based on automated literature extraction and
homology to interaction networks of other species. He
reported a final network of over 31,000 interactions between
7,748 human proteins. Allan Kuchinsky (Agilent Technolo-
gies, Palo Alto, USA) presented a freely available tool
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sysinformatics/downloadv2.html] for constructing litera-
ture-based networks de novo that can be combined with
experimental data. This tool has been implemented as a
plug-in to the network modeling software Cytoscape
[http://www.cytoscape.org].
Several initiatives aimed at generating interaction databases
were described, including BIND [http://www.bind.ca/Action]
(Chris Hogue, Samuel Lunenfeld Research Institute,
Toronto, Canada), HPRD [http://www.hprd.org] (Akhilesh
Pandey, Johns Hopkins University, Baltimore, USA) and
Reactome [http://www.reactome.org] (Ewan Birney, Euro-
pean Bioinformatics Institute, Hinxton, UK). In addition,
integration of interaction databases with visualization and
analysis tools requires standards for the representation of
molecular interaction data. Hennig Hermjakob (European
Bioinformatics Institute) described the latest developments
in the Protein Standards Initiative Molecular Interaction
(PSI-MI) XML language, which is increasingly accepted as
the standard for the exchange of interaction data. PSI-MI
has recently been adopted by the partners in the Interna-
tional Exchange Consortium (IMEx) who will exchange their
data in the form of XML files, following the PSI-MI standard
[http://imex.sourceforge.net].
Beyond literature curation and databases, interaction networks
present a number of major challenges to bioinformatics
researchers, such as how to enrich for the true interactions in
noisy measurements, how to best associate high-level infor-
mation about protein interactions with functional roles and,
most importantly, how to organize individual interaction
measurements into higher-order models of cellular signaling
and regulatory machinery. Several speakers discussed strate-
gies for constructing pathway models through the integration
of interaction datasets with each other and with other
genomic sources. One of us (T.I.) presented methods for com-
bining interaction and expression data to model regulatory
pathways, and for comparing networks across species to
identify their conserved regions, which then serve as markers
for evolutionary change. In his closing remarks, Marc Vidal
underscored the importance of assembling interactions into
biological models that are freely accessible to all.
The proposed data sharing between groups is reminiscent of
the early stages of the Human Genome Project. And indeed,
the similarities go further: as with genome sequencing ten
years ago, interaction-mapping projects are at different
stages of completion for human and for each model organ-
ism; experimental techniques are still being optimized and
further advances are needed; large databases are being con-
structed; and bioinformatic analyses are just beginning. We
will see at future meetings how far this analogy can be
extended, and whether, in fact, mapping the interaction
network will have the same revolutionary impact on biology
as mapping the human genome has had already.
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